Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetylcholine + blood is an experimental combination used in clinical research, specifically in studies led by Mark Gladwin, to investigate the physiological impact of blood storage duration on vascular health. Acetylcholine is administered intra-arterially as a pharmacological probe to induce endothelium-dependent vasodilation by stimulating the release of nitric oxide (NO). This response is measured in the presence of autologous blood stored for varying durations (e.g., 5-10 days versus 35-42 days). The research aims to characterize the 'storage lesion' in banked blood, where aged red blood cells may release cell-free hemoglobin and microparticles that scavenge NO, thereby impairing the vasodilatory response and potentially contributing to transfusion-related complications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetylcholine + blood.